tiprankstipranks

Richard Hawkins Insider Profile

4 Followers
Richard Hawkins, Director at Plus Therapeutics, holds 744.58K shares in Lumos Pharma (Ticker: LUMO), holds 0.00 shares in Savara (Ticker: SVRA), holds 0.00 shares in Sciclone Pharmaceuticals (Ticker: SCLN).
tipranks
Richard Hawkins

Richard Hawkins
Plus Therapeutics (PSTV)
Director

Ranked #59,566 out of 78,624 Corporate Insiders

Profitable Transactions

22%
2 out of 9 Profitable Transactions

Average Return

-11.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
98.56%
1.44%
0.00%
A breakdown of Richard Hawkins's holdings

Insider Roles

Lumos Pharma
(LUMO)
Chief Executive Officer, Director
Plus Therapeutics
(PSTV)
Director
Savara
(SVRA)
Director
Roles that Richard Hawkins holds in companies

Most Profitable Insider Trade

Stock:
Savara
(SVRA)
Rating:Informative Sell
Date:May 16, 2019 - May 16, 2020
Return:+80.20%
The most profitable trade made by Richard Hawkins

Richard Hawkins's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Plus Therapeutics
May 14, 2015
Director
Uninformative Buy
$162.97K
Savara
May 16, 2019
Director
Informative Sell
277.54K
$0.00
Lumos Pharma
Apr 03, 2020
Chief Executive Officer, Director
Uninformative Buy
$11.16M
SCLN
Sciclone Pharmaceuticals
Oct 16, 2017
Uninformative Sell
272.38K
$0.00
List of latest transactions for each holding click on a transaction to see Richard Hawkins's performance on stock

Richard Hawkins insider profile FAQ

What is the percentage of profitable transactions made by Richard Hawkins?
The percentage of profitable transactions made by Richard Hawkins is 22%.
    What is the average return per transaction made by Richard Hawkins?
    The average return per transaction made by Richard Hawkins is -11.50%.
      What stocks does Richard Hawkins hold?
      Richard Hawkins holds: PSTV, SVRA, LUMO, SCLN stocks.
        What was Richard Hawkins’s latest transaction?
        Richard Hawkins latest transaction was an Uninformative Buy of ―.
          What was Richard Hawkins's most profitable transaction?
          Richard Hawkins’s most profitable transaction was an Informative Sell of SVRA stock on May 16, 2019. The return on the trade was 80.20%.
            What is Richard Hawkins's role in Plus Therapeutics?
            Richard Hawkins's role in Plus Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.